Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SRE vs GSK✓SelectedUSD · GSKSRE vs GSK performance historyLatest closeAs of-0.17%11/20
Stock and ETF performance explorer

SRE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.6%
GSK return
+40.7%
Excess return
+1.9%
Maximum drawdown
-31.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-0.1%0.0%-0.1%
7D-4.2%-5.3%+1.1%-3.3%
30D-8.8%-3.7%-5.1%-8.2%
3M-12.1%-7.3%-4.9%-11.0%
6M-15.4%-4.2%-11.2%-15.0%
YTD-11.8%+0.9%-12.6%-12.6%
1Y-13.5%+7.3%-20.8%-15.3%
3Y+15.5%+52.7%-37.2%+2.1%
All+42.6%+40.7%+1.9%+18.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling